Related News

UCSF Enters Drug Discovery Agreement with Genentech
February 18, 2010 -- The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug ... 
19 Feb 2010
Business News, Research News
LRRK2 and alpha-synuclein: Made for each other?
Hot off the Neuron presses!!  Is alpha-synuclein aggregation and subsequent neurodegeneration exacerbated by LRRK2?  In a tour de force, Huaibin Cai’s group generated multiple LRRK2 ... 
23 Dec 2009
Research News
Parkinson's Disease Society Announces 2010 Innovation Grants
The Parkinson's Disease Society (PDS) invests in bold new ideas that have the potential to transform the lives of people with Parkinson's. Innovation grants support exceptionally innovative research ... 
07 Jan 2010
Funding News
Responses: 1
Request for Information: Soliciting Input on Huntington’s Disease Best Practice Guidelines for Therapeutic Target Validation
This is a time-sensitive Request for Information (RFI) issued by the National Institute of Neurological Disorders and Stroke. The purpose of this RFI is to solicit recommendations on the best ... 
05 Jan 2010
Funding News, Government News
Foundation Awards $2.5 Million for Parkinson's Drug Development Projects Led by Academic Investigators
1/28/2009 PRESS RELEASE This post was updated on November 19, 2009. ... 
27 Jan 2009
Funding News, MJFF Funded Projects: Abstracts, Progress, and Outcomes
Responses: 6
Michael J. Fox Foundation commits up to $12 million for targeted Parkinson's therapeutic development in 2010
NEW YORK, September 15, 2009 — The Michael J. Fox Foundation has committed up to $12 million in 2010 funding for prioritized research toward transformative treatments and a cure for ... 
15 Sep 2009
Funding News, MJFF Funded Projects: Abstracts, Progress, and Outcomes
Responses: 1
MJFF Awards over $2 Million for Validation of 10 Parkinson's Therapeutic Targets
NEW YORK, July 14, 2009 — The Michael J. Fox Foundation for Parkinson’s Research today announced approximately $2.1 million in total funding to 10 research teams working to validate ... 
04 Aug 2009
Funding News, MJFF Funded Projects: Abstracts, Progress, and Outcomes
Responses: 4
Michael J. Fox Foundation Awards $3.8 Million to Drive Nine Industry Partnerships for Pre-Clinical Parkinson's Drug Development
NEW YORK, July 21, 2009 — The Michael J. Fox Foundation for Parkinson’s Research has awarded research teams at nine biotech and pharmaceutical companies a total of $3.8 million for ... 
21 Jul 2009
Funding News, MJFF Funded Projects: Abstracts, Progress, and Outcomes
Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan
LONDON, Dec. 9 /PRNewswire/ -- The Parkinson's disease therapeutics market in 2008 amounted to over $1 billion in the European Union (EU), which includes total sales of carbidopa/levodopa, dopamine ... 
09 Dec 2009
Neurologix Completes All Surgical Procedures in Its Clinical Trial for Parkinson's Disease
FORT LEE, N.J., Dec 03, 2009 (BUSINESS WIRE) -- Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative therapies for the brain and central nervous ... 
04 Dec 2009
Business News